Neurobiology of obsessive-compulsive disorder: Insights into neural circuitry dysfunction through mouse genetics

Current Opinion in Neurobiology

Volumn 21, Issue 6, 2011, Pages 842-848

  Ting, Jonathan T ^a,b   Feng, Guoping ^a,b,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXCITATORY AMINO ACID TRANSPORTER 1; GLUTATHIONE; MEMBRANE PROTEIN; PROTEIN; SAP90 PSD95 ASSOCIATED PROTEIN 3; SAPAP3 PROTEIN; SLIT AND TRK LIKE PROTEIN; SLITRK PROTEIN; SLITRK1 PROTEIN; SLITRK5 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HOXB8; UNCLASSIFIED DRUG;

BEHAVIOR DISORDER; COGNITION; COMPULSION; CONCEPTUAL FRAMEWORK; CORTICOSTRIATALTHALAMOCORTICAL CIRCUITRY; GENE; GENETIC MODEL; GROOMING; HUMAN; MICROGLIA; NERVE TRACT; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; OXIDATIVE STRESS; PENETRANCE; POSTSYNAPTIC DENSITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SAPAP3 GENE; TRICHOTILLOMANIA;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MICE; OBSESSIVE-COMPULSIVE DISORDER;

EID: 84855483229     PISSN: 09594388     EISSN: 18736882     Source Type: Journal    
DOI: 10.1016/j.conb.2011.04.010     Document Type: Review

References (44)

1. Weissman M.M., Bland R.C., Canino G.J., Greenwald S., Hwu H.G., Lee C.K., Newman S.C., Oakley-Browne M.A., Rubio-Stipec M., Wickramaratne P.J., et al. The cross national epidemiology of obsessive compulsive disorder. The Cross National Collaborative Group. J Clin Psychiatry 1994, 55Suppl:5-10.
2. Karno M., Golding J.M., Sorenson S.B., Burnam M.A. The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry 1988, 45:1094-1099.
3. Jenike M.A. Clinical practice. obsessive-compulsive disorder. N Engl J Med 2004, 350:259-265.
4. Pittenger C., Krystal J.H., Coric V. Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder. NeuroRx 2006, 3:69-81.
5. Haynes W.I., Mallet L. High-frequency stimulation of deep brain structures in obsessive-compulsive disorder: the search for a valid circuit. Eur J Neurosci 2010, 32:1118-1127.
6. Saxena S., Rauch S.L. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr Clin North Am 2000, 23:563-586.
7. Alexander G.E., DeLong M.R., Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986, 9:357-381.
8. Albin R.L., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci 1989, 12:366-375.
9. DeLong M.R. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 1990, 13:281-285.
10. Canales J.J., Graybiel A.M. A measure of striatal function predicts motor stereotypy. Nat Neurosci 2000, 3:377-383.
11. Gerfen C.R. The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. Annu Rev Neurosci 1992, 15:285-320.
12. Wang L., Simpson H.B., Dulawa S.C. Assessing the validity of current mouse genetic models of obsessive-compulsive disorder. Behav Pharmacol 2009, 20:119-133.
13. Korff S., Harvey B.H. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology. Psychiatr Clin North Am 2006, 29:371-390.
14. Ting J.T., Feng G. Glutamatergic synaptic dysfunction and obsessive-compulsive disorder. Curr Chem Genomics 2008, 2:62-75.
15. Joel D. Current animal models of obsessive compulsive disorder: a critical review. Prog Neuropsychopharmacol Biol Psychiatry 2006, 30:374-388.
16. Boulougouris V., Chamberlain S.R., Robbins T.W. Cross-species models of OCD spectrum disorders. Psychiatry Res 2009, 170:15-21.
17. Welch J.M., Wang D., Feng G. Differential mRNA expression and protein localization of the SAP90/PSD-95-associated proteins (SAPAPs) in the nervous system of the mouse. J Comp Neurol 2004, 472:24-39.
18. Welch J.M., Lu J., Rodriguiz R.M., Trotta N.C., Peca J., Ding J.D., Feliciano C., Chen M., Adams J.P., Luo J., et al. Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature 2007, 448:894-900.
19. Zuchner S., Wendland J.R., Ashley-Koch A.E., Collins A.L., Tran-Viet K.N., Quinn K., Timpano K.C., Cuccaro M.L., Pericak-Vance M.A., Steffens D.C., et al. Multiple rare SAPAP3 missense variants in trichotillomania and OCD. Mol Psychiatry 2009, 14:6-9.
20. Bienvenu O.J., Wang Y., Shugart Y.Y., Welch J.M., Grados M.A., Fyer A.J., Rauch S.L., McCracken J.T., Rasmussen S.A., Murphy D.L., et al. Sapap3 and pathological grooming in humans: results from the OCD collaborative genetics study. Am J Med Genet B Neuropsychiatr Genet 2009, 150B:710-720.
21. Abelson J.F., Kwan K.Y., O'Roak B.J., Baek D.Y., Stillman A.A., Morgan T.M., Mathews C.A., Pauls D.L., Rasin M.R., Gunel M., et al. Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 2005, 310:317-320.
22. Zuchner S., Cuccaro M.L., Tran-Viet K.N., Cope H., Krishnan R.R., Pericak-Vance M.A., Wright H.H., Ashley-Koch A. SLITRK1 mutations in trichotillomania. Mol Psychiatry 2006, 11:887-889.
23. Stillman A.A., Krsnik Z., Sun J., Rasin M.R., State M.W., Sestan N., Louvi A. Developmentally regulated and evolutionarily conserved expression of SLITRK1 in brain circuits implicated in Tourette syndrome. J Comp Neurol 2009, 513:21-37.
24. Katayama K., Yamada K., Ornthanalai V.G., Inoue T., Ota M., Murphy N.P., Aruga J. Slitrk1-deficient mice display elevated anxiety-like behavior and noradrenergic abnormalities. Mol Psychiatry 2010, 15:177-184.
25. Shmelkov S.V., Hormigo A., Jing D., Proenca C.C., Bath K.G., Milde T., Shmelkov E., Kushner J.S., Baljevic M., Dincheva I., et al. Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice. Nat Med 2010, 16:598-602. 591p following 602.
26. Proenca C.C., Gao K.P., Shmelkov S.V., Rafii S., Lee F.S. Slitrks as emerging candidate genes involved in neuropsychiatric disorders. Trends Neurosci 2011, 34:143-153.
27. Greer J.M., Capecchi M.R. Hoxb8 is required for normal grooming behavior in mice. Neuron 2002, 33:23-34.
28. Chen S.K., Tvrdik P., Peden E., Cho S., Wu S., Spangrude G., Capecchi M.R. Hematopoietic origin of pathological grooming in Hoxb8 mutant mice. Cell 2010, 141:775-785.
29. Schlegelmilch T, Henke K, Peri F: Microglia in the developing brain: from immunity to behaviour. Curr Opin Neurobiol 2010.
30. Martino D., Defazio G., Giovannoni G. The PANDAS subgroup of tic disorders and childhood-onset obsessive-compulsive disorder. J Psychosom Res 2009, 67:547-557.
31. Scimemi A., Tian H., Diamond J.S. Neuronal transporters regulate glutamate clearance, NMDA receptor activation, and synaptic plasticity in the hippocampus. J Neurosci 2009, 29:14581-14595.
32. Aoyama K., Suh S.W., Hamby A.M., Liu J., Chan W.Y., Chen Y., Swanson R.A. Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse. Nat Neurosci 2006, 9:119-126.
33. Berman AE, Chan WY, Brennan AM, Reyes RC, Adler BL, Suh SW, Kauppinen TM, Edling Y, Swanson RA: N-acetylcysteine prevents loss of dopaminergic neurons in the EAAC1(-/-) mouse. Ann Neurol 2010.
34. Grados M.A. The genetics of obsessive-compulsive disorder and Tourette syndrome: an epidemiological and pathway-based approach for gene discovery. J Am Acad Child Adolesc Psychiatry 2010, 49(819):e811-812. 810-819.
35. Rothstein J.D., Martin L., Levey A.I., Dykes-Hoberg M., Jin L., Wu D., Nash N., Kuncl R.W. Localization of neuronal and glial glutamate transporters. Neuron 1994, 13:713-725.
36. Waxman E.A., Baconguis I., Lynch D.R., Robinson M.B. N-methyl-d-aspartate receptor-dependent regulation of the glutamate transporter excitatory amino acid carrier 1. J Biol Chem 2007, 282:17594-17607.
37. Arnold P.D., Rosenberg D.R., Mundo E., Tharmalingam S., Kennedy J.L., Richter M.A. Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study. Psychopharmacology (Berl) 2004, 174:530-538.
38. Wang Y., Adamczyk A., Shugart Y.Y., Samuels J.F., Grados M.A., Greenberg B.D., Knowles J.A., McCracken J.T., Rauch S.L., Murphy D.L., et al. A screen of SLC1A1 for OCD-related alleles. Am J Med Genet B Neuropsychiatr Genet 2009, 153B:675-679.
39. Bailey C.G., Ryan R.M., Thoeng A.D., Ng C., King K., Vanslambrouck J.M., Auray-Blais C., Vandenberg R.J., Broer S., Rasko J.E. Loss-of-function mutations in the glutamate transporter SLC1A1 cause human dicarboxylic aminoaciduria. J Clin Invest 2011, 121:446-453.
40. Lafleur D.L., Pittenger C., Kelmendi B., Gardner T., Wasylink S., Malison R.T., Sanacora G., Krystal J.H., Coric V. N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder. Psychopharmacology (Berl) 2006, 184:254-256.
41. Grant J.E., Odlaug B.L., Kim S.W. N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study. Arch Gen Psychiatry 2009, 66:756-763.
42. Leyfer O.T., Folstein S.E., Bacalman S., Davis N.O., Dinh E., Morgan J., Tager-Flusberg H., Lainhart J.E. Comorbid psychiatric disorders in children with autism: interview development and rates of disorders. J Autism Dev Disord 2006, 36:849-861.
43. Peca J., Feliciano C., Ting J.T., Wang W., Wells M.F., Venkatraman T.N., Lascola C.D., Fu Z., Feng G. Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 2011, 472:437-442.
44. Chao H.T., Chen H., Samaco R.C., Xue M., Chahrour M., Yoo J., Neul J.L., Gong S., Lu H.C., Heintz N., et al. Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 2010, 468:263-269.